BCC Stock Recent News

BCC LATEST HEADLINES

BCC Stock News Image - businesswire.com

BOISE, Idaho--(BUSINESS WIRE)--Boise Cascade Company's (Boise Cascade or the Company) (NYSE: BCC) Board of Directors declared a quarterly dividend of $0.22 per share, an increase of $0.01 per share or 5%, to holders of its common stock. The dividend will be paid on September 17, 2025 to stockholders of record on September 2, 2025. Future dividend declarations, including amount per share, record date and payment date, will be made by the board of directors and will depend upon, among other thing.

businesswire.com 2025 Jul 31
BCC Stock News Image - zacks.com

Boise Cascade (BCC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com 2025 Jul 28
BCC Stock News Image - seekingalpha.com

Graham All Star Value (GASV) strategy identifies top dividend 'dogs' offering high yield and fair pricing, using YCharts' large cap value and Ben Graham screens. Analyst projections suggest the top ten GASV stocks could deliver average net gains of 27.55% by July 2026, with moderate risk. Sixteen of the twenty-one lowest-priced, 'safer' GASV dividend stocks are currently buyable, with dividends exceeding share price for ideal picks.

seekingalpha.com 2025 Jul 25
BCC Stock News Image - businesswire.com

BOISE, Idaho--(BUSINESS WIRE)--Boise Cascade Company (NYSE: BCC) will host a webcast and conference call to discuss 2025 second quarter earnings on Tuesday, August 5, 2025, at 11 a.m. Eastern. To join the webcast, go to the Investors section of our website at www.bc.com/investors and select the Event Calendar link. Analysts and investors who wish to ask questions during the Q&A session can register for the call here. The archived webcast will be available in the Investors section of Boise C.

businesswire.com 2025 Jul 22
BCC Stock News Image - seekingalpha.com

The market's rally is all Big Tech and hype, but beneath the surface, breadth is weak and valuations are stretched. This isn't a great setup for index investors. Fortunately, this is still a market of stocks. Bottom-up targets show real value in sectors like energy, healthcare, and real estate. That's why I'm zooming in on two dirt-cheap dividend plays, under-the-radar names with strong fundamentals and serious long-term upside.

seekingalpha.com 2025 Jul 13
BCC Stock News Image - businesswire.com

BOISE, Idaho--(BUSINESS WIRE)--Boise Cascade Company (Boise Cascade) (NYSE: BCC) announced today that Rob Johnson is stepping into a new role as Senior Vice President of Manufacturing for their Wood Products division, effective June 16, 2025. This move will backfill the role previously filled by Chris Seymour, who left the organization earlier in June. In this role, Rob will oversee the operations for the company's 18+ manufacturing facilities across the U.S. He will continue to report to Troy.

businesswire.com 2025 Jun 13
BCC Stock News Image - zacks.com

Boise Cascade (BCC) reported earnings 30 days ago. What's next for the stock?

zacks.com 2025 Jun 04
BCC Stock News Image - zacks.com

BCC, DOOO and CMT have been added to the Zacks Rank #5 (Strong Sell) List on May 28, 2025.

zacks.com 2025 May 28
BCC Stock News Image - seekingalpha.com

Long-term stock investing works. Historically, holding for 20+ years has never led to losses. I want more than just average returns, so I aim higher. I avoid ETFs and prefer concentrated bets in sectors I know well. My focus is on high-conviction picks I believe can double far faster than the market. In this article, I'm sharing three dividend stocks that are higher-risk, higher-reward. Even if I'm wrong, I believe they're still solid long-term investments.

seekingalpha.com 2025 May 23
BCC Stock News Image - newsfilecorp.com

The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval from the UAE DOH to commence Phase 2 clinical study (SKNJCT-004) to non-invasively treat BCC of the skin.

newsfilecorp.com 2025 May 22
10 of 50